Mark C Walters (Mark Walters)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Venues

American journal of hematology

The New England journal of medicine

UCSF Benioff Children's Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UCSF Benioff Children's Hospital Jan 02 2019

United States

Professor :: Pediatrics

Publications

Haydar Frangoul, Franco Locatelli, Akshay Sharma, Monica Bhatia, Markus Mapara, Lyndsay Molinari, Donna Wall, Robert I Liem, Paul Telfer, Ami J Shah, Marina Cavazzana, Selim Corbacioglu, Damiano Rondelli, Roland Meisel, Laurence Dedeken, Stephan Lobitz, Mariane de Montalembert, Martin H Steinberg, Mark C Walters, Michael J Eckrich, Suzan Imren, Laura Bower, Christopher Simard, Weiyu Zhou, Fengjuan Xuan, Phuong Khanh Morrow, William E Hobbs, Stephan A Grupp, null null
Exagamglogene Autotemcel for Severe Sickle Cell Disease. The New England journal of medicine 390 (18) (2024)
Mary Eapen, Jianqun Kou, Martin Andreansky, Monica Bhatia, Joel Brochstein, Sonali Chaudhury, Ann E Haight, Hilary Haines, David Jacobsohn, Jennifer Jaroscak, Kimberly A Kasow, Lakshmanan Krishnamurti, John E Levine, Kathryn Leung, David Margolis, Lolie C Yu, Mary M Horowitz, Naynesh Kamani, Mark C Walters, Shalini Shenoy
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. American journal of hematology 99 (4) (2024)
Mary Eapen, Jianqun Kou, Martin Andreansky, Monica Bhatia, Joel Brochstein, Sonali Chaudhury, Ann E Haight, Hilary Haines, David Jacobsohn, Jennifer Jaroscak, Kimberly A Kasow, Lakshmanan Krishnamurti, John E Levine, Kathryn Leung, David Margolis, Lolie C Yu, Mary M Horowitz, Naynesh Kamani, Mark C Walters, Shalini Shenoy
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. American journal of hematology 99 (4) (2024)
Mary Eapen, Jianqun Kou, Martin Andreansky, Monica Bhatia, Joel Brochstein, Sonali Chaudhury, Ann E Haight, Hilary Haines, David Jacobsohn, Jennifer Jaroscak, Kimberly A Kasow, Lakshmanan Krishnamurti, John E Levine, Kathryn Leung, David Margolis, Lolie C Yu, Mary M Horowitz, Naynesh Kamani, Mark C Walters, Shalini Shenoy
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. American journal of hematology 99 (4) (2024)
Mary Eapen, Jianqun Kou, Martin Andreansky, Monica Bhatia, Joel Brochstein, Sonali Chaudhury, Ann E Haight, Hilary Haines, David Jacobsohn, Jennifer Jaroscak, Kimberly A Kasow, Lakshmanan Krishnamurti, John E Levine, Kathryn Leung, David Margolis, Lolie C Yu, Mary M Horowitz, Naynesh Kamani, Mark C Walters, Shalini Shenoy
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. American journal of hematology 99 (4) (2024)
Haydar Frangoul, Franco Locatelli, Akshay Sharma, Monica Bhatia, Markus Mapara, Lyndsay Molinari, Donna Wall, Robert I Liem, Paul Telfer, Ami J Shah, Marina Cavazzana, Selim Corbacioglu, Damiano Rondelli, Roland Meisel, Laurence Dedeken, Stephan Lobitz, Mariane de Montalembert, Martin H Steinberg, Mark C Walters, Michael J Eckrich, Suzan Imren, Laura Bower, Christopher Simard, Weiyu Zhou, Fengjuan Xuan, Phuong Khanh Morrow, William E Hobbs, Stephan A Grupp, null null
Exagamglogene Autotemcel for Severe Sickle Cell Disease. The New England journal of medicine (2024)
Haydar Frangoul, Franco Locatelli, Akshay Sharma, Monica Bhatia, Markus Mapara, Lyndsay Molinari, Donna Wall, Robert I Liem, Paul Telfer, Ami J Shah, Marina Cavazzana, Selim Corbacioglu, Damiano Rondelli, Roland Meisel, Laurence Dedeken, Stephan Lobitz, Mariane de Montalembert, Martin H Steinberg, Mark C Walters, Michael J Eckrich, Suzan Imren, Laura Bower, Christopher Simard, Weiyu Zhou, Fengjuan Xuan, Phuong Khanh Morrow, William E Hobbs, Stephan A Grupp, null null
Exagamglogene Autotemcel for Severe Sickle Cell Disease. The New England journal of medicine 390 (18) (2024)
Haydar Frangoul, Franco Locatelli, Akshay Sharma, Monica Bhatia, Markus Mapara, Lyndsay Molinari, Donna Wall, Robert I Liem, Paul Telfer, Ami J Shah, Marina Cavazzana, Selim Corbacioglu, Damiano Rondelli, Roland Meisel, Laurence Dedeken, Stephan Lobitz, Mariane de Montalembert, Martin H Steinberg, Mark C Walters, Michael J Eckrich, Suzan Imren, Laura Bower, Christopher Simard, Weiyu Zhou, Fengjuan Xuan, Phuong Khanh Morrow, William E Hobbs, Stephan A Grupp, null null
Exagamglogene Autotemcel for Severe Sickle Cell Disease. The New England journal of medicine 390 (18) (2024)
Mary Eapen, Jianqun Kou, Martin Andreansky, Monica Bhatia, Joel Brochstein, Sonali Chaudhury, Ann E Haight, Hilary Haines, David Jacobsohn, Jennifer Jaroscak, Kimberly A Kasow, Lakshmanan Krishnamurti, John E Levine, Kathryn Leung, David Margolis, Lolie C Yu, Mary M Horowitz, Naynesh Kamani, Mark C Walters, Shalini Shenoy
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. American journal of hematology (2024)
Mary Eapen, Jianqun Kou, Martin Andreansky, Monica Bhatia, Joel Brochstein, Sonali Chaudhury, Ann E Haight, Hilary Haines, David Jacobsohn, Jennifer Jaroscak, Kimberly A Kasow, Lakshmanan Krishnamurti, John E Levine, Kathryn Leung, David Margolis, Lolie C Yu, Mary M Horowitz, Naynesh Kamani, Mark C Walters, Shalini Shenoy
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. American journal of hematology 99 (4) (2024)
Selim Corbacioglu, Haydar Frangoul, Franco Locatelli, William Hobbs, Mark C Walters
Defining curative endpoints for transfusion-dependent β-thalassemia in the era of gene therapy and gene editing. American journal of hematology 99 (3) (2023)
Selim Corbacioglu, Haydar Frangoul, Franco Locatelli, William Hobbs, Mark C Walters
Defining curative endpoints for transfusion-dependent β-thalassemia in the era of gene therapy and gene editing. American journal of hematology 99 (3) (2023)
Franco Locatelli, Selim Corbacioglu, William Hobbs, Haydar Frangoul, Mark C Walters
Defining curative endpoints for sickle cell disease in the era of gene therapy and gene editing. American journal of hematology (2023)
Selim Corbacioglu, Haydar Frangoul, Franco Locatelli, William Hobbs, Mark C Walters
Defining curative endpoints for transfusion-dependent β-thalassemia in the era of gene therapy and gene editing. American journal of hematology (2023)
Selim Corbacioglu, Haydar Frangoul, Franco Locatelli, William Hobbs, Mark C Walters
Defining curative endpoints for transfusion-dependent β-thalassemia in the era of gene therapy and gene editing. American journal of hematology 99 (3) (2023)
Julie Kanter, Alexis A Thompson, Francis J Pierciey, Matthew Hsieh, Naoya Uchida, Philippe Leboulch, Manfred Schmidt, Melissa Bonner, Ruiting Guo, Alex Miller, Jean-Antoine Ribeil, David Davidson, Mohammed Asmal, Mark C Walters, John F Tisdale
Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study. American journal of hematology (2022)
Mark C Walters
Induction of Fetal Hemoglobin by Gene Therapy. The New England journal of medicine 384 (3) (2021)
Julie Kanter, Mark C Walters, Lakshmanan Krishnamurti, Markus Y Mapara, Janet L Kwiatkowski, Stacey Rifkin-Zenenberg, Banu Aygun, Kimberly A Kasow, Francis J Pierciey, Melissa Bonner, Alex Miller, Xinyan Zhang, Jessie Lynch, Dennis Kim, Jean-Antoine Ribeil, Mohammed Asmal, Sunita Goyal, Alexis A Thompson, John F Tisdale
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease. The New England journal of medicine 386 (7) (2021)
Franco Locatelli, Alexis A Thompson, Janet L Kwiatkowski, John B Porter, Adrian J Thrasher, Suradej Hongeng, Martin G Sauer, Isabelle Thuret, Ashutosh Lal, Mattia Algeri, Jennifer Schneiderman, Timothy S Olson, Ben Carpenter, Persis J Amrolia, Usanarat Anurathapan, Axel Schambach, Christian Chabannon, Manfred Schmidt, Ivan Labik, Heidi Elliot, Ruiting Guo, Mohammed Asmal, Richard A Colvin, Mark C Walters
Betibeglogene Autotemcel Gene Therapy for Non-β0/β0 Genotype β-Thalassemia. The New England journal of medicine (2021)
John F Tisdale, Francis J Pierciey, Melissa Bonner, Alexis A Thompson, Lakshmanan Krishnamurti, Markus Y Mapara, Janet L Kwiatkowski, Ilya Shestopalov, Jean-Antoine Ribeil, Wenmei Huang, Mohammed Asmal, Julie Kanter, Mark C Walters
Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial. American journal of hematology 95 (9) (2020)

Mark C Walters.css-eqlu8i{font-size:small;padding-left:4px;} (Mark Walters)

Publication Activity (10 Years)

Top Topics

Top Venues

Mark C Walters (Mark Walters)